{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:42:29Z","timestamp":1790667749126,"version":"4.1.0"},"reference-count":39,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"11","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>Hodgkin lymphoma (HL) is classified as the first malignancy to be cured by a combination of chemotherapy and radiotherapy. However, the life expectancy of HL survivors is hampered by the occurrence of late adverse events, including second malignant neoplasms (SMNs) and cardiovascular diseases (CVDs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS AND METHODS<\/jats:title>\n            <jats:p>We investigated the causes of death in a cohort of 1,435 patients over age 15 years treated at 18 different public cancer centers in Chile.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>\n              After a median follow-up of 19 years (0-37), the 5-year overall survival improved from 64% in the cohort 1985-1994 to 81% in the cohort 2009-2014 (\n              <jats:italic>P<\/jats:italic>\n              &lt; .001). HL was the main cause of death in the first 10 years after treatment, whereas SMN and CVD risk peaked 10-15 years and remained raised for 30 years or longer. Cumulative incidence of deaths (CIDs) due to SMNs resulted significantly higher in patients treated with cyclophosphamide, vincristine, procarbazine, prednisone (MOPP)\/MOPP-like regimens over doxorubicin, bleomycin, vinblastine, dacarbazine. CIDs due to CVDs increased from 0.4 to 4.1 at 5 and 20 years, respectively.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>HL survivors continue to have a reduced life expectancy due to an increased risk of dying of SMNs and\/or CVDs, although it was lower among patients treated in the most recent calendar period studied (2002-2014).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/go-24-00344","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T19:59:19Z","timestamp":1746475159000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort Study"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9059-3871","authenticated-orcid":true,"given":"Maria Elena","family":"Cabrera","sequence":"first","affiliation":[{"name":"Hospital del Salvador, Universidad de Chile, Santiago de Chile, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8606-5806","authenticated-orcid":true,"given":"Monica","family":"Civallero","sequence":"additional","affiliation":[{"name":"CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-193X","authenticated-orcid":true,"given":"Yana","family":"Stepanishyna","sequence":"additional","affiliation":[{"name":"Hematology Department, Jules Bordet Institute, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Derio","sequence":"additional","affiliation":[{"name":"Oncology Nurse, Public Health Magister, Universidad de Chile, Universidad Mayor, Santiago de Chile, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2276-869X","authenticated-orcid":true,"given":"Tetiana","family":"Skrypets","sequence":"additional","affiliation":[{"name":"Hematology Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivianne","family":"Lois","sequence":"additional","affiliation":[{"name":"Hospital Barros Luco Trudeaux, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeska","family":"Vega","sequence":"additional","affiliation":[{"name":"Hospital San Juan de Dios, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Calderon","sequence":"additional","affiliation":[{"name":"Hospital Regional de Valdivia, Valdivia, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Rojas","sequence":"additional","affiliation":[{"name":"Hospital S\u00f3tero del R\u00edo, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Pizarro","sequence":"additional","affiliation":[{"name":"Hospital San Borja Arriar\u00e1n, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5937-2804","authenticated-orcid":true,"given":"M. Gabriela","family":"Mendoza","sequence":"additional","affiliation":[{"name":"Hospital Regional de Talca, Talca, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Romero","sequence":"additional","affiliation":[{"name":"Hospital Regional de Concepcion, Concepcion, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8626-4434","authenticated-orcid":true,"given":"Christine","family":"Rojas","sequence":"additional","affiliation":[{"name":"Hospital Gustavo Fricke, Vi\u00f1a del Mar, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Oliva","sequence":"additional","affiliation":[{"name":"Hospital Las Higueras de Talcahuano, Talcahuano, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvila","family":"Intriago","sequence":"additional","affiliation":[{"name":"Hospital Regional de La Serena, La Serena, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardita","family":"Rojas","sequence":"additional","affiliation":[{"name":"Hospital Carlos van Buren, Valparaiso, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-3478","authenticated-orcid":true,"given":"Luana","family":"Conte","sequence":"additional","affiliation":[{"name":"Department of Physics and Chemistry, University of Palermo, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Marcheselli","sequence":"additional","affiliation":[{"name":"Fondazione Italiana Linfomi, Trial Office Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9889-3796","authenticated-orcid":true,"given":"Massimo","family":"Federico","sequence":"additional","affiliation":[{"name":"CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0189-6"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26717"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3140"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.8268"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.07.131"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3131"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505949"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.3.487"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.05.021"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.1180"},{"key":"e_1_3_6_12_2","first-page":"126","article-title":"High risk of cardiovascular side effects after treatment of Hodgkin\u2019s lymphoma\u2014Is there a need for intervention in long-term survivors?","volume":"10","author":"Andersson A","year":"2021","unstructured":"Andersson A, Melin B, Enblad G, et al: High risk of cardiovascular side effects after treatment of Hodgkin\u2019s lymphoma\u2014Is there a need for intervention in long-term survivors? Ups J Med Sci 10:126, 2021","journal-title":"Ups J Med Sci"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.476"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa194"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08683-x"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.07.131"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s44228-022-00008-4"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.804"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19586"},{"key":"e_1_3_6_20_2","first-page":"1403","article-title":"Overall survival and causes of death in elderly patients with Hodgkin lymphoma: A Norwegian population-based case-control study","volume":"109","author":"Lia K","year":"2024","unstructured":"Lia K, J\u00f8rgensen RRK, Wold BL, et al: Overall survival and causes of death in elderly patients with Hodgkin lymphoma: A Norwegian population-based case-control study. Haematologica 109:1403-1412, 2024","journal-title":"Haematologica"},{"key":"e_1_3_6_21_2","first-page":"33","article-title":"Long-term survival in Hodgkin\u2019s disease relative impact of mortality, second tumors, infection, and cardiovascular disease","volume":"1","author":"Mauch PM","year":"1995","unstructured":"Mauch PM, Kalish LA, Marcus KC, et al: Long-term survival in Hodgkin\u2019s disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am 1:33-42, 1995","journal-title":"Cancer J Sci Am"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.0936"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.08.021"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rchic.2016.10.014"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.6832"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.177"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271929"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.10.004"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00264"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34375"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010061"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.4444"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103326"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00562"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-11947-w"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34065"},{"key":"e_1_3_6_38_2","unstructured":"National Comprehensive Cancer Network (NCCN) guidelines version 2.2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hodgkin_blocks.pdf"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.08.097"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000001072"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-24-00344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T19:59:21Z","timestamp":1746475161000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-24-00344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1200\/GO-24-00344"],"URL":"https:\/\/doi.org\/10.1200\/go-24-00344","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2024-07-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400344"}}